Log in to search using one of your social media accounts:

 

Quickly Treating Mini-Stroke Can Cut Risk for Future Stroke
MONDAY, Nov. 20, 2017 -- Prompt treatment of a mini-stroke could reduce the likelihood of having a full-blown stroke by roughly 80 percent, according to a new report. People who have a mini-stroke -- officially called a transient ischemic attack... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 20, 2017 Category: General Medicine Source Type: news

Malnutrition India's biggest health hazard, air pollution a close second
Ischaemic heart disease that is greatly influenced by air pollution has gone up from rank 5 to number 1, diabetes from rank 22 to rank 5 and stroke from rank 16 to rank 15. (Source: The Economic Times)
Source: The Economic Times - November 15, 2017 Category: Consumer Health News Source Type: news

Stryker touts NEJM publication of Trevo thrombectomy device trial results
Stryker (NYSE:SYK) yesterday released results from the Dawn trial of its Trevo thrombectomy device, touting significant effects even when used beyond six hours after stroke. Results from the trial were published in the New England Journal of Medicine, the Kalamazoo, Mich.-based company said. “By quadrupling the size of the therapeutic time window, the consequence of Dawn is that many more patients with large vessel occlusion stroke have the potential to be treated with mechanical thrombectomy.  Dawn validates the physiological, rather than time-based approach to patient selection for endovascular therapy,&r...
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular Stryker Source Type: news

Population-based study of ischemic stroke risk after trauma in children and young adults - Fox CK, Hills NK, Vinson DR, Numis AL, Dicker RA, Sidney S, Fullerton HJ.
OBJECTIVE: To quantify the incidence, timing, and risk of ischemic stroke after trauma in a population-based young cohort. METHODS: We electronically identified trauma patients (... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Final Watchman Trial Analyses Encourage Experts, but Caveats Remain Final Watchman Trial Analyses Encourage Experts, but Caveats Remain
It garnered kudos for preventing cerebral bleeds, caution about an ischemic stroke signal. But interventionalists liked the LAA occluder for"people who cannot or will not" take long-term anticoagulants.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 3, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

TCT 2017: Boston Scientific touts lowered hemorrhagic stroke rate, cost for patients in Watchman studies
Boston Scientific (NYSE:BSX) today released combined 5-year outcomes data from both the Prevail and Protect-AF study of its Watchman left atrial appendage closure device, touting it as a safe and effective an alternative to long-term warfarin therapy for patients with non-valvular atrial fibrillation. Five-year data from the Prevail study was published online today in the Journal of the American College of Cardiology. In both trials, the Marlborough, Mass.-based company compared the Watchman device to warfarin treatment for stroke prevention in patients with non-valvular AF with follow-ups out to five years. A combine...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news

Men lacking a caregiver face a greater risk of being placed in a nursing home after stroke
(Wiley) A Journal of the American Geriatrics Society study found that in men aged 65 and older who survived an ischemic stroke, the lack of an available caregiver was associated with triple the risk of nursing home placement within five years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 27, 2017 Category: International Medicine & Public Health Source Type: news

' Alarming' Increase in Stroke Risk Factors'Alarming' Increase in Stroke Risk Factors
Despite many prevention initiatives, the prevalence of hypertension, diabetes, dyslipidemia, drug abuse, and smoking actually appears to be increasing among new ischemic stroke patients in the United States, a new study shows.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 17, 2017 Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news

Scorpion bite-induced ischaemic stroke - Reddy C R, Bompelli N, Khardenavis V, Deshpande A.
We report a 54-year-old woman with scorpion bite. After 3  hours of admission, the patient developed sudden onset tachycardia with hypotension. Cardiac evaluation showed raised creatine kinase MB isoenzyme was elevated; ECG and two-dimensional echocardiog... (Source: SafetyLit)
Source: SafetyLit - October 16, 2017 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news

Russian study pits InspireMD ’ s CGuard device against Abbott ’ s Rx Acculink carotid stent
InspireMD (NYSE:NSPR) this week touted an independent clinical trial in Russia pitting its CGuard embolic protection device against the Rx Acculink carotid stent made by Abbott (NYSE:ABT). The 100-patient trial is designed to compare the two devices in terms of neuroprotection and clinical superiority in subjects undergoing carotid endarterectomy, the Tel Aviv-based company said. Conducted at the Scientific Research Institute of Circulation Pathology in Novosibirsk, the study is led by Dr. Andrei Karpenko. The primary endpoint is new ischemic areas in the brain 24 to 48 hours post-procedure and new lesi...
Source: Mass Device - October 12, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Stents InspireMD Stroke Source Type: news

2004 to 2014 Saw Increases in Risk Factors in Ischemic Stroke
Increases in prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse in AIS (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 12, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Emergency Medicine, Neurology, Nursing, Pathology, Pulmonology, Journal, Source Type: news

Ischemic stroke patients not receiving life-saving treatment, study finds
(Georgia State University) Ischemic stroke patients who do not receive intravelous (IV) alteplase, a clot-dissolving medication, are significantly less likely to survive, according to researchers at Georgia State University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 12, 2017 Category: International Medicine & Public Health Source Type: news

Stroke Risk Factors Are Rising
More people survive these brain attacks, but the health problems that cause stroke aren't going awaySource: HealthDay Related MedlinePlus Pages: High Blood Pressure, Ischemic Stroke, Stroke (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 11, 2017 Category: Consumer Health News Source Type: news

Risk Factors for Seizures, Epilepsy After Stroke Risk Factors for Seizures, Epilepsy After Stroke
Hemorrhagic transformation and the degree of neurologic compromise were independent risk factors for seizures or epilepsy after thrombolysis for ischemic stroke, a study shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Thrombolysis for Ischemic Stroke After Reversal of Dabigatran Thrombolysis for Ischemic Stroke After Reversal of Dabigatran
Is idarucizumab administration safe and effective in patients with AF treated with dabigatran who develop acute ischemic stroke requiring thrombolysis?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Integra LifeSciences completes purchase of J & J ’ s Codman Neurosurgery
Integra LifeSciences (Nasdaq: IART) has completed its previously announced $1.045 billion purchase of Johnson & Johnson’s Codman Neurosurgery business, the companies announced today. “The addition of Codman Neurosurgery expands our global leadership position by creating one of the broadest medical device portfolios in the neurosurgery market,” Peter Arduini, Integra’s president and CEO, said in a news release. “Our planned investments in product innovation and global infrastructure will allow us to provide more healthcare solutions to surgeons and their patients worldwide,” Arduini s...
Source: Mass Device - October 2, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News News Well Wall Street Beat Codman Neuro Integra LifeSciences Corp. johnsonandjohnson Natus Medical Inc. Source Type: news

Acute Ischemic Stroke Care: Guide to Mechanical Thrombectomy Acute Ischemic Stroke Care: Guide to Mechanical Thrombectomy
While wide acceptance of mechanical thrombectomy has led to a revolution in acute ischemic stroke care, questions remain on how to implement it safely and effectively. Get guidance in this article.Practical Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

LivaNova nabs 510(k) clearance for Optiflow Arterial cannulae
LivaNova (NSDQ:LIVN) said today that it won 510(k) clearance from the FDA for its family of Optiflow Arterial cannulae. The London-based company touted its aortic arch cannula as providing improved hydrodynamics and boasting a novel dispersive tip that boosts blood flow characteristics and reduces wall shear stress profiles. Optiflow Arterial cannulae have a “basket tip with large openings,” LivaNova reported, which has been shown to significantly reduce wall shear stress and turbulence. This feature could help lessen ischemic complications from extracorporeal circulation during cardiac surgery, the compan...
Source: Mass Device - September 25, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: 510(k) Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Wall Street Beat LivaNova Source Type: news

What Causes Microcephaly?
Patient Presentation A 5-month-old male came to clinic for his health supervision visit and followup from his neonatal intensive care stay. He was born prematurely at 28 weeks gestation and his stay was complicated by a right sided Grade III intraventricular hemorrhage, a left-sided Grade IV intraventricular hemorrhage, neonatal seizures, respiratory distress and bronchopulmonary dysplasia, retinopathy of prematurity, acute kidney injury that had resolved, possible necrotizing enterocolitis incidents x 2, and herpes simplex encephalitis. He was on home oxygen, a nasogastric feeding tube because of aspiration risk and mult...
Source: PediatricEducation.org - September 25, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Claret Medical touts Sentinel data in TAVR study
Claret Medical today released results from a study of its Sentinel cerebral protection system, touting reduced early occurrence of stroke associated with transcatheter aortic valve replacement procedures and lowered mortality rates. The study of the device was recently published in the Journal of the American College of Cardiology: Cardiovascular Interventions, the Santa Rosa, Calif.-based company said. The Sentinel embolic protection device is designed to trap blood clots and prevent stroke during heart valve replacement procedures, which Claret Medical touts as the 1st and only FDA-cleared device to do so. “In...
Source: Mass Device - September 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Neurological Claret Medical Inc. Source Type: news

Data Boosts Support for Abbott, Gore PFO Closure Tech
Devices designed to lower a patient's stroke risk by surgically closing a hole in the heart known as a patent foramen ovale, have historically had a tough time in clinical trials. Data from three separate studies published in the New England Journal of Medicine could go a long way toward boosting support two market-leading PFO closure devices, but figuring out who should have the procedure and who should not continues to be a gray area for clinicians and patients. Long-term results from the RESPECT trial, which evaluated the Amplatzer device that Abbott acquired when it bought St. Jude Medical, along with new dat...
Source: MDDI - September 15, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis R Medical Device Business Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 15, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA cuts could threaten medtech innovation: Here’s why The Trump administration’s proposed federal budget could hurt the speed and quality of FDA review times, says a top expert at Musculoskeletal Clinical Regulator...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Studies support anti-stroke PFO closure devices from Abbott, Gore
Sykes and Clark; licensee BioMed Central Ltd. A trio of studies published this week in the New England Journal of Medicine showed that devices from Abbott (NYSE:ABT) and W.L. Gore & Assoc. designed to close a heart defect lowered the risk of a recurring episode in certain cryptogenic stroke patients. Long-term results from the 980-patient Respect trial of the Amplatzer device Abbott acquired along with St. Jude Medical this year, along with data from the Reduce study of Gore’s Helex and Cardioform and the French Close study of PFO closure devices with CE Mark approval, showed that they reduced the risk of re...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Surgical Abbott Structural heart W.L. Gore & Associates Source Type: news

DiaMedica begins Phase II trial to treat acute ischemic stroke
US-based biopharmaceutical firm DiaMedica Therapeutics has begun a Phase II clinical trial (REMEDY) of its therapeutic candidate DM199 for the treatment of patients with acute ischemic stroke. (Source: Drug Development Technology)
Source: Drug Development Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news

Early Anticoagulation Strategies Comparable After Afib-Related Stroke (CME/CE)
(MedPage Today) -- NOAC, warfarin show similar safety and efficacy after mild acute ischemic stroke (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 11, 2017 Category: Cardiology Source Type: news

Ischemic Stroke May Hint at Underlying Cancer Ischemic Stroke May Hint at Underlying Cancer
Undiagnosed cancer may trigger ischemic stroke events by inducing hypercoagulability, say Spanish researchers. The findings suggest that in particular, older stroke patients should be followed closely.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Ischemic Stroke May Hint at Underlying Cancer
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 8, 2017 Category: General Medicine Source Type: news

Higher Childhood BMI Linked to Higher Stroke Risk (CME/CE)
(MedPage Today) -- Concerns about coming increases in cases of early ischemic stroke (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 21, 2017 Category: Cardiology Source Type: news

Ischemic Stroke Complicating Thrombolytic Therapy for STEMI Ischemic Stroke Complicating Thrombolytic Therapy for STEMI
These two cases highlight the rare complication of ischemic stroke following fibrinolytic therapy for STEMI. What mechanism might explain this paradoxical occurrence?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 21, 2017 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Radioiodine Therapy for Thyroid Cancer Doesn ’ t Up Stroke Risk
I - 131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 19, 2017 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Neurology, Oncology, ENT, Radiology, Journal, Source Type: news

New Tool Predicts Bleeding Risk After TIA, Ischemic Stroke New Tool Predicts Bleeding Risk After TIA, Ischemic Stroke
The S2TOP-BLEED score can be used in clinical practice to identify patients receiving antiplatelet therapy who are at high risk for major bleeding after transient ischemic attack or ischemic stroke.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 15, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Short - Term Risk of Arterial Embolism Up in Cancer Patients
Increased risk of arterial thromboembolism, MI, ischemic stroke for cancer patients (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 15, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Oncology, Journal, Source Type: news

An engineered S1P chaperone attenuates hypertension and ischemic injury
We report the development of a soluble carrier for S1P, ApoM-Fc, which activated S1P receptors in a sustained manner and promoted endothelial function. In contrast, ApoM-Fc did not modulate circulating lymphocyte numbers, suggesting that it specifically activated endothelial S1P receptors. ApoM-Fc administration reduced blood pressure in hypertensive mice, attenuated myocardial damage after ischemia/reperfusion injury, and reduced brain infarct volume in the middle cerebral artery occlusion model of stroke. Our proof-of-concept study suggests that selective and sustained targeting of endothelial S1P receptors by ApoM-Fc co...
Source: Signal Transduction Knowledge Environment - August 15, 2017 Category: Science Authors: Swendeman, S. L., Xiong, Y., Cantalupo, A., Yuan, H., Burg, N., Hisano, Y., Cartier, A., Liu, C. H., Engelbrecht, E., Blaho, V., Zhang, Y., Yanagida, K., Galvani, S., Obinata, H., Salmon, J. E., Sanchez, T., Di Lorenzo, A., Hla, T. Tags: STKE Research Articles Source Type: news

Neural Analytics launches study of transcranial doppler for evaluating mild-TBI
Neural Analytics said today it enrolled the 1st patient in a 2-year study exploring the use of its Lucid M1 transcranial doppler ultrasound system to evaluate cerebral blood flow in patients with mild traumatic brain injuries. The Lucid M1 system is a portable all-in-one ultrasound system designed for measuring and displaying cerebral blood flow velocities in patients with brain disorders, the Los Angeles, Calif.-based company said. In the 240-patient trial, researchers at the University of California Los Angeles will examine high school and college age enrollees in 3 separate groups, including those who have been affected...
Source: Mass Device - August 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Diagnostics Neurological Neural Analytics Source Type: news

Men Driving Decrease in Stroke (CME/CE)
(MedPage Today) -- Men now on par with women for ischemic stroke (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 10, 2017 Category: Cardiology Source Type: news

Statins Overlooked for Secondary Stroke Prevention Statins Overlooked for Secondary Stroke Prevention
A nationwide study found one-fifth of patients discontinued statins 3 to 6 months after discharge for an ischemic stroke, while another study found less than half were ever prescribed a statin upon leaving the hospital.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Tenecteplase Not Better or Safer in Ischemic Stroke
(MedPage Today) -- First head-to-head trial shows no advantage against alteplase (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 3, 2017 Category: American Health Source Type: news

Stopping Statins After Stroke May Raise Risk of Another
WEDNESDAY, Aug. 2, 2017 -- Stroke survivors who stop taking cholesterol-lowering statins are at increased risk for another stroke, a new study finds. Researchers studied more than 45,000 ischemic stroke survivors who were prescribed a statin within... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 2, 2017 Category: General Medicine Source Type: news

Less Than Half of U.S. Stroke Patients Get Rx for Statins
WEDNESDAY, Aug. 2, 2017 -- Fewer than half of U.S. stroke survivors are prescribed cholesterol-lowering statins, a new study finds. Statins are recommended for patients who have had an ischemic stroke or mini-stroke (transient ischemic attack) to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 2, 2017 Category: General Medicine Source Type: news

10 Factors to Predict Bleeding Risk in Stroke Survivors
WEDNESDAY, Aug. 2, 2017 -- Stroke survivors at high risk for bleeding from drugs meant to prevent another stroke can be identified using a new scoring system, new research contends. Many patients who have an ischemic stroke -- which occurs when a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 2, 2017 Category: General Medicine Source Type: news

Excellance Finishes New Mobile Stroke Unit Packed With All of the Latest Medical Technology to Diagnose and Treat Strokes
Excellance has delivered a new Mobile Stroke Unit (MSU) to Indiana University Health. These units are best-in-class for saving lives, preserving brain function, reducing post-hospitalization costs, and cutting alarm-to-therapy decision time by half. Indiana University Health Neurology and Neurosurgery features the latest and greatest in the world of healthcare, adding another tool to their stewardship in the world of neurological care and live-saving treatments. The latest in medical technology, the MSU features an onboard mobile CT scanner, lab, and telemedicine unit, allowing the doctor to interface with the unit and ...
Source: JEMS: Journal of Emergency Medical Services News - July 30, 2017 Category: Emergency Medicine Authors: Excellance Tags: Industry News Operations Source Type: news

Excellance Finishes New Mobile Stroke Unit Packed With All of the Latest Medical Technology to Diagnose and Treat Strokes
Excellance has delivered a new Mobile Stroke Unit (MSU) to Indiana University Health. These units are best-in-class for saving lives, preserving brain function, reducing post-hospitalization costs, and cutting alarm-to-therapy decision time by half. Indiana University Health Neurology and Neurosurgery features the latest and greatest in the world of healthcare, adding another tool to their stewardship in the world of neurological care and live-saving treatments. The latest in medical technology, the MSU features an onboard mobile CT scanner, lab, and telemedicine unit, allowing the doctor to interface with the unit and ...
Source: JEMS Operations - July 30, 2017 Category: Emergency Medicine Authors: Excellance Tags: Industry News Operations Source Type: news

Patients With TIA or Stroke on Aspirin May Benefit From Another Antiplatelet Drug Patients With TIA or Stroke on Aspirin May Benefit From Another Antiplatelet Drug
Patients who have a transient ischemic attack (TIA) or stroke while they're on aspirin may have better vascular health and avoid future strokes if they add or switch to another antiplatelet agent within days, a new meta-analysis suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 25, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for July 25, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. How a single drop of blood can detect sepsis Sepsis can be identified by a single drop of blood, thanks to a lab-on-a-chip device from the University of Illinois. Researchers at the University of Illinois and the Carle Foundati...
Source: Mass Device - July 25, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Stroke, TIA Survivors Without Early Complications Still Face Increased Long-Term Risks (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD Adults who are clinically stable in the early period after a stroke or transient ischemic attack face increased risks for adverse outcomes years later, according to a Canadian Medical Association … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 24, 2017 Category: Primary Care Source Type: news

FDA recalls Penumbra 3D Revascularization device over wire separation issues
The FDA today released a recall notice for Penumbra‘s (NYSE:PEN) 3D Revascularization Device, part of its Penumbra system designed to remove thrombus from brain blood vessels during strokes, over issues with wire breaks and separations. The FDA labeled the recall as Class I, its most serious designation, indicating that there is a reasonable probability that use of the product could cause serious adverse health consequences or death. The 3D Revascularization device is designed to restore blood flow or remove blood clots in blood vessels in the brain during acute ischemic stroke in patients who are ineligible or ...
Source: Mass Device - July 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Neurological Recalls Vascular Penumbra Inc. Source Type: news

Silk Road Medical raises $47m
Silk Road Medical said today it raised $47 million in a new funding round to support its Enroute products designed for transcarotid artery revascularization procedures. The round was led by newly invested Norwest Venture Partners and Janus Capital Management funds and joined by existing investors Warburg Pincus, The Vertical Group and CRG, the Sunnyvale, Calif.-based company said. Silk Road’s Enroute neuroprotection system is designed to allow physicians direct access to the common carotid artery in the neck to initiate high rate temporary blood flow reversal to protect the brain from stroke during implantations...
Source: Mass Device - July 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Vascular Silk Road Medical Inc. Source Type: news

Isolated Atypical Transient Symptoms in a Cohort With TIA Isolated Atypical Transient Symptoms in a Cohort With TIA
Isolated atypical transient symptoms, such as partial sensory deficit, vertigo, visual deficit, or diplopia can be associated with many diagnoses. How often do they indicate transient ischemic attack?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Does coffee make you live longer?
Conclusion This study, conducted on a large number of people across Europe, was backed up by similar findings in the US. It appears to show some association between people who drink higher amounts of coffee and a reduced risk of death. But the "potentially beneficial clinical implications" need to be considered carefully for a number of reasons: Although the analyses were adjusted for some confounding variables, there may be a number of other factors that differ between the groups that account for the differences in death, such as socioeconomic status, family history, other medical conditions, and use of medic...
Source: NHS News Feed - July 12, 2017 Category: Consumer Health News Tags: Food/diet Source Type: news

Higher Coated-platelet Levels Tied to Increased Stroke Risk After TIA Higher Coated-platelet Levels Tied to Increased Stroke Risk After TIA
A higher percentage of coated-platelets following transient ischemic attack (TIA) is associated with an increased risk of stroke in the ensuing 30 days, researchers report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - July 5, 2017 Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news